We target innovative, emerging medical device investment opportunities and provide value-added assistance to support the growth of our portfolio companies into market leaders.

SightLine Partners' investment strategy is focused on compelling investment opportunities that provide the potential for outsized returns regardless of stage. The medical device industry is a fast changing landscape which provides an abundance of opportunities for knowledgeable investors. Our focus across the spectrum of investment stages allows SightLine to find value regardless of overall financial market conditions. We seek companies with unique and proprietary technologies that address significant unmet needs in high value therapeutic areas such as vascular diseases, diabetes, spine, stroke prevention and treatment of pulmonary disease.